Monsenso A/S (CPH:MONSO)
0.2000
+0.0050 (2.56%)
Oct 15, 2025, 1:00 PM CET
Monsenso Revenue
Monsenso had revenue of 5.17M DKK in the half year ending June 30, 2025, with 17.17% growth. This brings the company's revenue in the last twelve months to 10.80M, up 0.58% year-over-year. In the year 2024, Monsenso had annual revenue of 11.17M with 16.01% growth.
Revenue (ttm)
10.80M
Revenue Growth
+0.58%
P/S Ratio
1.35
Revenue / Employee
900.33K
Employees
13
Market Cap
14.55M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.17M | 1.54M | 16.01% |
Dec 31, 2023 | 9.62M | 3.41M | 54.90% |
Dec 31, 2022 | 6.21M | -930.00K | -13.02% |
Dec 31, 2021 | 7.14M | -1.92M | -21.19% |
Dec 31, 2020 | 9.06M | 283.00K | 3.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 311.94B |
Coloplast | 27.87B |
Genmab | 23.16B |
Demant | 22.59B |
ALK-Abelló | 5.86B |
H. Lundbeck | 23.52B |
Zealand Pharma | 9.11B |
Ambu A/S | 5.96B |